Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John T Barr

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 24, 2011
Inhibition of human liver aldehyde oxidase: implications for potential drug-drug interactionsJohn T Barr, Jeffrey P Jones
Methods in Molecular Biology (Clifton, N.J.)|July 17, 2021
Case Study 1: Practical Considerations with Experimental Design and InterpretationJohn T Barr, Otito F Iwuchukwu
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 22, 2012
Evidence for substrate-dependent inhibition profiles for human liver aldehyde oxidaseJohn T Barr, Jeffrey P Jones
Methods in Molecular Biology (Clifton, N.J.)|February 14, 2014
Enzyme kinetics, inhibition, and regioselectivity of aldehyde oxidaseJohn T Barr, Kanika Choughule, Jeffrey P Jones
Methods in Molecular Biology (Clifton, N.J.)|February 14, 2014
Case study 1. Practical considerations with experimental design and interpretationJohn T Barr, Darcy R Flora, Otito F Iwuchukwu
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 7, 2013
Evaluation of rhesus monkey and guinea pig hepatic cytosol fractions as models for human aldehyde oxidaseKanika V Choughule, John T Barr, Jeffrey P Jones
Methods in Molecular Biology (Clifton, N.J.)|July 17, 2021
Enzyme Kinetics, Pharmacokinetics, and Inhibition of Aldehyde OxidaseErickson M Paragas, Kanika Choughule, Jeffrey P Jones, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 9, 2019
Fraction Unbound for Liver Microsome and Hepatocyte Incubations for All Major Species Can Be Approximated Using a Single-Species SurrogateJohn T Barr, Julie M Lade, Thuy B Tran, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 19, 2014
Inhibition of human aldehyde oxidase activity by diet-derived constituents: structural influence, enzyme-ligand interactions, and clinical relevanceJohn T Barr, Jeffrey P Jones, Nicholas H Oberlies, et al.
Molecular Pharmaceutics|September 7, 2013
Absolute quantification of aldehyde oxidase protein in human liver using liquid chromatography-tandem mass spectrometryJohn T Barr, Jeffrey P Jones, Carolyn A Joswig-Jones, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 24, 2011
Inhibition of human liver aldehyde oxidase: implications for potential drug-drug interactionsJohn T Barr, Jeffrey P Jones
Methods in Molecular Biology (Clifton, N.J.)|July 17, 2021
Case Study 1: Practical Considerations with Experimental Design and InterpretationJohn T Barr, Otito F Iwuchukwu
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 22, 2012
Evidence for substrate-dependent inhibition profiles for human liver aldehyde oxidaseJohn T Barr, Jeffrey P Jones
Methods in Molecular Biology (Clifton, N.J.)|February 14, 2014
Enzyme kinetics, inhibition, and regioselectivity of aldehyde oxidaseJohn T Barr, Kanika Choughule, Jeffrey P Jones
Methods in Molecular Biology (Clifton, N.J.)|February 14, 2014
Case study 1. Practical considerations with experimental design and interpretationJohn T Barr, Darcy R Flora, Otito F Iwuchukwu
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 7, 2013
Evaluation of rhesus monkey and guinea pig hepatic cytosol fractions as models for human aldehyde oxidaseKanika V Choughule, John T Barr, Jeffrey P Jones
Methods in Molecular Biology (Clifton, N.J.)|July 17, 2021
Enzyme Kinetics, Pharmacokinetics, and Inhibition of Aldehyde OxidaseErickson M Paragas, Kanika Choughule, Jeffrey P Jones, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 9, 2019
Fraction Unbound for Liver Microsome and Hepatocyte Incubations for All Major Species Can Be Approximated Using a Single-Species SurrogateJohn T Barr, Julie M Lade, Thuy B Tran, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 19, 2014
Inhibition of human aldehyde oxidase activity by diet-derived constituents: structural influence, enzyme-ligand interactions, and clinical relevanceJohn T Barr, Jeffrey P Jones, Nicholas H Oberlies, et al.
Molecular Pharmaceutics|September 7, 2013
Absolute quantification of aldehyde oxidase protein in human liver using liquid chromatography-tandem mass spectrometryJohn T Barr, Jeffrey P Jones, Carolyn A Joswig-Jones, et al.
Pageof 2